DLHC:NASDAQDLH Holdings Corp. Analysis
Data as of 2026-03-29 - not real-time
$5.59
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
DLH Holdings Corp. is trading at $5.59, just above the calculated support of $5.50 and well below its book value of $7.74, yielding a low price‑to‑book of 0.72 and a price‑to‑sales of 0.25. The company’s revenue fell 24% YoY to $322.6 M and it posted a negative trailing EPS of –$0.08, while operating cash flow remains positive at $29.9 M. Despite these fundamentals, the DCF model implies a fair value of $20.74, suggesting roughly 79% upside, and the technicals show a bullish SMA alignment (20‑day SMA above 50‑day and 200‑day SMAs) with a rising volume trend. However, the MACD is bearish (negative line, histogram below zero) and the RSI sits at 44.5, indicating neutral momentum, and the 30‑day volatility is high at 46.8%.
The balance sheet is strained: cash of $0.26 M versus debt of $149.8 M creates a debt‑to‑equity of 133.5, and the forward PE is –19.96, reflecting earnings weakness. The stock has a single analyst target of $10 and a “Greed” market sentiment (Fear & Greed Index 65.9). High volatility, a sizable max drawdown of –34.8%, and limited liquidity (average volume ~10k) add to the risk profile, while the company’s federal‑contract focus introduces moderate regulatory exposure.
The balance sheet is strained: cash of $0.26 M versus debt of $149.8 M creates a debt‑to‑equity of 133.5, and the forward PE is –19.96, reflecting earnings weakness. The stock has a single analyst target of $10 and a “Greed” market sentiment (Fear & Greed Index 65.9). High volatility, a sizable max drawdown of –34.8%, and limited liquidity (average volume ~10k) add to the risk profile, while the company’s federal‑contract focus introduces moderate regulatory exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Price flirting with support at $5.50
- Bearish MACD signal
- Elevated short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Significant upside potential from DCF valuation
- Improving operating cash flow but persistent earnings loss
- High debt load limiting financial flexibility
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Substantial valuation gap versus book value and DCF estimate
- Strategic federal contract exposure offering stable revenue base
- Potential for turnaround if cost discipline and revenue growth materialize
Key Metrics & Analysis
Financial Health
Revenue Growth-24.10%
Profit Margin-0.33%
P/E Ratio-20.0
ROE-0.96%
ROA2.58%
Debt/Equity133.53
P/B Ratio0.7
Op. Cash Flow$30.0M
Free Cash Flow$33.9M
Industry P/E28.1
Technical Analysis
TrendBullish
RSI44.5
Support$5.50
Resistance$6.25
MA 20$5.82
MA 50$5.80
MA 200$5.73
MACDBearish
VolumeIncreasing
Fear & Greed Index65.98
Valuation
Fair Value$20.74
Target Price$10.00
Upside/Downside78.89%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.67
Volatility46.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.